Macrophages and Age-Related Macular Degeneration

Overview

Journal Adv Exp Med Biol

Date 2025 Feb 10

PMID 39930165

Authors

Evangeline Foster

Amanda-Jayne Carr

Affiliations

Soon will be listed here.

Abstract

Age-related macular degeneration (AMD) is characterised by the dysfunction of the retinal pigment epithelium (RPE), deposition of drusen and degeneration of the overlying photoreceptors, leading to the loss of central vision. AMD is a complex and multifactorial disease, with the greatest risk factor being age. As we age, changes occur to our immune system, a phenomenon known as inflammageing. There is mounting evidence indicating a role for the immune system in the development, progression, pathology and potentially, treatment of AMD. However, the specific contribution played by immune cells remains unclear. This chapter discusses evidence implicating a role for the circulating macrophages in AMD.

References

Ambati J, Anand A, Fernandez S, Sakurai E, Lynn B, Kuziel W . An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003; 9(11):1390-7. DOI: 10.1038/nm950. View

Anderson D, Mullins R, Hageman G, Johnson L . A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002; 134(3):411-31. DOI: 10.1016/s0002-9394(02)01624-0. View

Apte R, Richter J, Herndon J, Ferguson T . Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 2006; 3(8):e310. PMC: 1539093. DOI: 10.1371/journal.pmed.0030310. View

Cao X, Shen D, Patel M, Tuo J, Johnson T, Olsen T . Macrophage polarization in the maculae of age-related macular degeneration: a pilot study. Pathol Int. 2011; 61(9):528-35. PMC: 3292787. DOI: 10.1111/j.1440-1827.2011.02695.x. View

Costantini A, Viola N, Berretta A, Galeazzi R, Matacchione G, Sabbatinelli J . Age-related M1/M2 phenotype changes in circulating monocytes from healthy/unhealthy individuals. Aging (Albany NY). 2018; 10(6):1268-1280. PMC: 6046240. DOI: 10.18632/aging.101465. View

De Maeyer R, Chambers E . The impact of ageing on monocytes and macrophages. Immunol Lett. 2020; 230:1-10. DOI: 10.1016/j.imlet.2020.12.003. View

Droho S, Thomson B, Makinde H, Cuda C, Perlman H, Lavine J . Ocular macrophage origin and heterogeneity during steady state and experimental choroidal neovascularization. J Neuroinflammation. 2020; 17(1):341. PMC: 7666512. DOI: 10.1186/s12974-020-02010-0. View

Duvall J, Tso M . Cellular mechanisms of resolution of drusen after laser coagulation. An experimental study. Arch Ophthalmol. 1985; 103(5):694-703. DOI: 10.1001/archopht.1985.01050050086024. View

Edwards A, Ritter 3rd R, Abel K, Manning A, Panhuysen C, Farrer L . Complement factor H polymorphism and age-related macular degeneration. Science. 2005; 308(5720):421-4. DOI: 10.1126/science.1110189. View

10.

Fritsche L, Igl W, Cooke Bailey J, Grassmann F, Sengupta S, Bragg-Gresham J . A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2015; 48(2):134-43. PMC: 4745342. DOI: 10.1038/ng.3448. View

11.

Gu B, Baird P, Vessey K, Skarratt K, Fletcher E, Fuller S . A rare functional haplotype of the P2RX4 and P2RX7 genes leads to loss of innate phagocytosis and confers increased risk of age-related macular degeneration. FASEB J. 2013; 27(4):1479-87. DOI: 10.1096/fj.12-215368. View

12.

Hagbi-Levi S, Grunin M, Elbaz-Hayoun S, Tal D, Obolensky A, Hanhart J . Retinal Phenotype following Combined Deletion of the Chemokine Receptor CCR2 and the Chemokine CX3CL1 in Mice. Ophthalmic Res. 2015; 55(3):126-34. DOI: 10.1159/000441794. View

13.

Hageman G, Luthert P, Chong N, JOHNSON L, Anderson D, Mullins R . An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001; 20(6):705-32. DOI: 10.1016/s1350-9462(01)00010-6. View

14.

Haines J, Hauser M, Schmidt S, Scott W, Olson L, Gallins P . Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005; 308(5720):419-21. DOI: 10.1126/science.1110359. View

15.

Jiao H, Rutar M, Fernando N, Yednock T, Sankaranarayanan S, Aggio-Bruce R . Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration. Mol Neurodegener. 2018; 13(1):45. PMC: 6102844. DOI: 10.1186/s13024-018-0278-0. View

16.

JOHNSON L, Leitner W, Staples M, Anderson D . Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res. 2002; 73(6):887-96. DOI: 10.1006/exer.2001.1094. View

17.

Kelly J, Khan A, Yin J, Ferguson T, Apte R . Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest. 2007; 117(11):3421-6. PMC: 2045608. DOI: 10.1172/JCI32430. View

18.

Killingsworth M, Sarks J, Sarks S . Macrophages related to Bruch's membrane in age-related macular degeneration. Eye (Lond). 1990; 4 ( Pt 4):613-21. DOI: 10.1038/eye.1990.86. View

19.

Klein R, Zeiss C, Chew E, Tsai J, Sackler R, Haynes C . Complement factor H polymorphism in age-related macular degeneration. Science. 2005; 308(5720):385-9. PMC: 1512523. DOI: 10.1126/science.1109557. View

20.

Lad E, Cousins S, Van Arnam J, Proia A . Abundance of infiltrating CD163+ cells in the retina of postmortem eyes with dry and neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2015; 253(11):1941-5. PMC: 5203931. DOI: 10.1007/s00417-015-3094-z. View